Expression of transforming growth factor β type II receptor reduces tumorigenicity in human gastric cancer cells

Cancer Research

Volumn 57, Issue 14, 1997, Pages 2856-2859

  Chang, Jay ^a   Park, Keunchil ^b   Bang, Yung Jue ^c   Kim, Won Seog ^b   Kim, David ^a,d   Kim, Seong Jin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL ACETYLTRANSFERASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; VIRUS VECTOR;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETROVIRUS; STOMACH CANCER; STOMACH EPITHELIUM;

ANIMALS; CELL DIVISION; HUMANS; MICE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030793369     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
2. Park, K., Kim, S-J., Bang, Y-J., Park, J-G., Kim, N. K., Roberts, A. B., and Sporn, M. B. Genetic changes in the transforming growth factor β (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β. Proc. Natl. Acad. Sci. USA, 91: 8772-8776, 1994.
3. Roberts, A. B., and Sporn, M. B. Peptide growth factors and their receptors. In: A. B. Robert and M. B. Sporn (eds.), Handbook of Experimental Pharmacology, pp. 419-472. Heidelberg, Germany: Springer-Verlag, 1990.
4. Massagué, J., Attisano, L., and Wrana, J. The TGF-β family and its composite receptors. Trends Cell Biol., 4: 172-178, 1994.
5. Lin, H., Wang, X-F., Ng-Eaton, E., Weinberg, R., and Lodish, H. Expression cloning of the TGF-β type II receptor a functional transmembrane serine/threonine kinase. Cell, 68: 775-785, 1992.
6. Wrana, J. L., Attisano, L., Carcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X., and Massagué, J. TGF-β signals through a heteromeric protein kinase receptor complex. Cell, 71: 1003-1014, 1992.
7. Franzén, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., and Miyazono, K. Cloning of a TGF-β type 1 receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell, 75: 681-692, 1993.
8. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massagué, J. Mechanism of activation of the TGF-β receptor. Nature (Lond.), 370: 341-347, 1994.
9. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., Sun, L. Z., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., Brattain, M. G., and Willson, J. K. V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science (Washington DC), 268: 1336-1338, 1995.
10. Capocasale, R., Lamb, R., Vonderheid, E. C., Fox, F. E., Rook, A. H., Nowell, P. C., and Moore, J. S. Reduced surface expression of transforming growth factor β receptor type II in mitogen-activated T cells from Sézary patients. Proc. Natl. Acad. Sci. USA 92: 5501-5505, 1995.
11. Kadin, M., Cavaille-Coll, M. W., Gertz, R., Massagué, J., Cheifetz, S., and George, D. Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA. 91: 6002-6006, 1994.
12. Kim, D. H., and Kim, S-J. Transforming growth factor β receptors: role in physiology and disease. J. Biomed. Sci., 3: 143-158, 1996.
13. Parsons, R., Myeroff, L. L., Liu, B. L., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Microsatellile instability and mutations of the transforming growth factor β type II receptor gene in colorectal cancer. Cancer Res., 55: 5548-5550, 1995.
14. Myeroff, L. L., Parsons, R., Kim, S-J., Hedrick, L., Cho, K. R., Orth, K., Mathis, M., Kinzler, K. W., Lutterbaugh, J., Park, K., Bamg, Y-J., Lee, H. Y., Park, J-G., Lynch, H. T., Roberts, A. B., Vogelstein, B., and Markowitz, S. D. A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res., 55: 5545-5547, 1995.
15. Inagaki, M., Moustaka, A., Lin, H. Y., Lodish, H. F., and Carr, B. I. Growth inhibition by transforming growth factor β-resistant hepatoma cells after expression of TGF-β receptor type II cDNA. Proc. Natl. Acad. Sci. USA, 90: 5359-5363, 1993.
16. Wang, J., Sun, L., Myeroff, L. L., Wang, X., Gentry, L. E., Yang, J., Liang, J., Zborowska, E., Markowitz, S., Willson, J. K. V., and Brattain, M. G. Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J. Biol. Chem., 270: 22044-22049, 1995.
17. Kim, I. Y., Ahn, H-J., Zelner, D. J., Shaw, J. W., Sensibar, J. A., Kim, J-H., Kato, M., and Lee, C. Genetic change in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivity to TGF-β1 in human prostate cancer cells. Cancer Res., 56: 44-48, 1996.
18. Park, J-G., Yang, H-K., Kim, W. H., Chung, J-K., Kang, M-S., Lee, J-H., Oh, J. H., Park, H-S., Yeo, K-S., Kang, S. H., Song, S-Y., Kang, Y. K., Bang, Y-J., Kim, Y. I., and Kim, J. P. Establishment and characterization of human gastric carcinoma cell lines. Int. J. Cancer, 70: 443-449, 1997.
19. Ohashi, T., Boggs, S., Robbins, P., Bahnson, A., Patrene, K., Wei, F-S., Wei, J-F., Li, J., Lucht, L., Fei, Y., Clark, S., Kimak, M., He, H., Mowery-Rushton, P., and Barranger, J. A. Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. Proc. Natl. Acad. Sci. USA, 89: 11332-11336, 1992.
20. Dranoff, G., Jaffee, E., Lazenby, A., Golubek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. Vaccination with irradiated minor cells engineered to secrete murine granulocyte macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc. Natl. Acad Sci. USA. 90: 3539-3543, 1993.
21. Boivin, G. P., Molina, J. R., Ormsby, I., Stemmermann, G., and Doetschman, T. Gastric lesions in transforming growth factor β-1 heterozygous mice. Lab. Invest., 74: 513-518, 1996.